Characterization of a large panel of patient-derived tumor xenografts representing the clinical heterogeneity of human colorectal cancer.
about
Patient-derived tumor xenografts: transforming clinical samples into mouse modelsPatient-derived xenograft models of colorectal cancer in pre-clinical research: a systematic reviewAn Integrative Approach to Precision Cancer Medicine Using Patient-Derived XenograftsColorectal cancer models for novel drug discoveryOne mouse, one patient paradigm: New avatars of personalized cancer therapyMouse models of colorectal cancer as preclinical modelsPrioritizing therapeutic targets using patient-derived xenograft modelsCetuximab response in CRC patient-derived xenografts seems predicted by an expression based RAS pathway signatureEstablishment, characterization and chemosensitivity of three mismatch repair deficient cell lines from sporadic and inherited colorectal carcinomasFrom bench to bedside: lessons learned in translating preclinical studies in cancer drug developmentEstablishment and characterization of 7 novel hepatocellular carcinoma cell lines from patient-derived tumor xenograftsCharacterization of Breast Cancer Preclinical Models Reveals a Specific Pattern of Macrophage PolarizationSystematic chemical and molecular profiling of MLL-rearranged infant acute lymphoblastic leukemia reveals efficacy of romidepsinThe future of patient-derived tumor xenografts in cancer treatment.Vasculature analysis of patient derived tumor xenografts using species-specific PCR assays: evidence of tumor endothelial cells and atypical VEGFA-VEGFR1/2 signalingsPersonalising pancreas cancer treatment: When tissue is the issue.Patient-derived xenografts, the cancer stem cell paradigm, and cancer pathobiology in the 21st century.Modeling RAS phenotype in colorectal cancer uncovers novel molecular traits of RAS dependency and improves prediction of response to targeted agents in patientsSpontaneous genomic alterations in a chimeric model of colorectal cancer enable metastasis and guide effective combinatorial therapyPatient-derived xenograft models: an emerging platform for translational cancer researchIn-vivo fusion of human cancer and hamster stromal cells permanently transduces and transcribes human DNA.The promise of patient-derived xenografts: the best laid plans of mice and menEstablishment and characterization of cell lines from chromosomal instable colorectal cancer.Gene mutations in primary tumors and corresponding patient-derived xenografts derived from non-small cell lung cancer.Phenotypic and transcriptional fidelity of patient-derived colon cancer xenografts in immune-deficient miceSetting up a wide panel of patient-derived tumor xenografts of non-small cell lung cancer by improving the preanalytical steps.Establishment and characterization of patient-derived tumor xenograft using gastroscopic biopsies in gastric cancer.Patient-Derived Gastric Carcinoma Xenograft Mouse Models Faithfully Represent Human Tumor Molecular Diversity.Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes.Correlation between tumor engraftment in patient-derived xenograft models and clinical outcomes in colorectal cancer patientsOrganoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer.Genomic characterization of a large panel of patient-derived hepatocellular carcinoma xenograft tumor models for preclinical developmentIn vivo and ex vivo cetuximab sensitivity assay using three-dimensional primary culture system to stratify KRAS mutant colorectal cancer.High-throughput high-volume nuclear imaging for preclinical in vivo compound screening§Multi-parameter systematic strategies for predictive, preventive and personalised medicine in cancer.Establishment and characterisation of patient-derived xenografts as paraclinical models for gastric cancer.Application of single-cell RNA sequencing in optimizing a combinatorial therapeutic strategy in metastatic renal cell carcinoma.Origin of the vasculature supporting growth of primary patient tumor xenografts.Delineation of MGMT Hypermethylation as a Biomarker for Veliparib-Mediated Temozolomide-Sensitizing Therapy of GlioblastomaA short-term colorectal cancer sphere culture as a relevant tool for human cancer biology investigation.
P2860
Q24627425-D0C02E57-D237-47B3-9851-F9DAC6822AF3Q26741651-ECB4ADD4-944C-4CF4-8291-19C6E7CDEEEAQ26772895-4C04FBBC-67AD-46C9-A84D-5F5FEDE70747Q26795724-BF4586C9-CEE2-42FD-B8F1-B8890CE423C2Q27023342-79E3DD23-3EA7-4C05-B853-A8B5E3B79CCFQ28081871-FE042F95-3BC9-4080-A96A-3FA593F0798CQ28083993-87B8AA6B-5052-42AC-B803-FBC664A8FD5CQ28468648-573A0D3D-8AE4-40A8-A839-3FCC359480DCQ28484668-FC996081-9FC2-4213-8CF0-4E4EFF516C6CQ28533949-33716CAF-72AD-4A6C-8232-27724E7854D2Q28538581-E0DE36B5-9022-4B18-BE29-4252CD6432F3Q28552410-4872245E-B49C-4920-ABBF-09EF97B81374Q28817780-0519DC58-9CC1-4421-B148-F40DE2F7C4E8Q33361578-7A6375B0-CFC8-4823-B8B0-3C7C21E8ACABQ33557623-F250A776-EE8D-42BB-BC8E-F545C93DDB11Q33801384-902518C0-3B2E-4603-9B42-DCF5A32F7C48Q34037747-7CD703FB-6DE0-4490-9C5C-B59219144E87Q34078212-2B08E9D6-4767-4222-A21F-911123CA62AAQ34097654-1718396C-8ABD-41CD-A70A-C8F0B21AEED1Q34205518-CF816DC6-25DF-4BBB-BBA0-4FB5B9C8FBBCQ34258171-8C028B75-B6C7-4294-B412-7B53EE141952Q34443008-F59BB8B5-728A-4457-A678-D98DDF1AED89Q34827208-FA5269FD-45F6-4644-923C-C36AFD39C8B0Q34994030-B636614C-CADA-4F25-AEEE-A3EA13138705Q35053317-611D2C06-353D-4923-A097-DA7C8FE79F74Q35084915-631C9B27-4640-43DE-9A17-0F80FBD63D16Q35119526-FAC65156-333D-4D28-B961-F105B83A5B2BQ35719104-F989BFD8-C5D5-4ABB-8AA1-9690C5F1F53DQ35760892-B37072BE-5726-4AE3-9982-B3DD38B20954Q36140720-1C067D44-9631-4B30-87C3-893AF4E038FBQ36164867-DD21CDEE-178D-41AB-882C-EEB790E51ED9Q36299617-C0104EE1-30B7-4873-AD86-072C250E7A9BQ36310845-F37155BF-AF43-4040-BE51-808F7DD034CFQ36340673-735EFB4B-16BC-43F2-A1A7-9A5D78A5AB11Q36588615-A54A9999-40C9-4405-88C4-5018DA502ABDQ36633405-D857F628-6D84-45F9-A331-9F4FF8E16528Q36855805-AFB1FE8D-8B37-480E-8D46-9FCBC299E19BQ36863454-16293EC0-A759-4322-BA06-02CFF8BC6423Q36887663-D682A087-662E-42F0-9BE1-AD3B29487078Q36889620-18A17646-C12D-4121-9C9D-B3127E38278D
P2860
Characterization of a large panel of patient-derived tumor xenografts representing the clinical heterogeneity of human colorectal cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Characterization of a large pa ...... ty of human colorectal cancer.
@en
Characterization of a large pa ...... ty of human colorectal cancer.
@nl
type
label
Characterization of a large pa ...... ty of human colorectal cancer.
@en
Characterization of a large pa ...... ty of human colorectal cancer.
@nl
prefLabel
Characterization of a large pa ...... ty of human colorectal cancer.
@en
Characterization of a large pa ...... ty of human colorectal cancer.
@nl
P2093
P921
P1476
Characterization of a large pa ...... ty of human colorectal cancer.
@en
P2093
Alain Bruno
Alain Pierré
Ana Merino-Trigo
Bastien Job
Brigitte Demers
Cyril Berthet
Denis Lantuas
Emmanuel Pham
Fariba Nemati
Grégoire Prévost
P304
P356
10.1158/1078-0432.CCR-12-0372
P407
P577
2012-07-23T00:00:00Z